Martin Stockler describes the Enzalutamide in First-Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET) trial, which shows mixed effects of enza on QOL in prostate cancer.
The Uromigos Episode 165: Paper of the Month—ENZAMET Quality of Life Data
By The Uromigos - Last Updated: October 21, 2022
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.